Zobrazeno 1 - 10
of 1 561
pro vyhledávání: '"Von Kries JP"'
Autor:
van Hoof S; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany., Kreye J; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany; Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Cordero-Gómez C; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany., Hoffmann J; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany., Momsen Reincke S; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Sánchez-Sendin E; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany., Duong SL; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany., Upadhya M; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK., Dhangar D; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK., Michór P; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK., Woodhall GL; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK., Küpper M; Oscar Langendorff Institute of Physiology, University of Rostock, Germany, Center of Transdisciplinary Neurosciences Rostock (CTNR), Germany., Oder A; Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany., Kuchling J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Neurocure Cluster of Excellence, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany., Koch SP; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany., Mueller S; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany., Boehm-Sturm P; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany., von Kries JP; Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany., Finke C; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Neurocure Cluster of Excellence, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany., Kirschstein T; Oscar Langendorff Institute of Physiology, University of Rostock, Germany, Center of Transdisciplinary Neurosciences Rostock (CTNR), Germany., Wright SK; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK; Department of Paediatric Neurology, The Birmingham Women's and Children's Hospital National Health Service Foundation Trust, Birmingham, UK., Prüss H; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany. Electronic address: harald.pruess@charite.de.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2024 Nov; Vol. 122, pp. 266-278. Date of Electronic Publication: 2024 Aug 13.
Autor:
Wąsińska-Kałwa M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Omran A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Mach L; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Scipioni L; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Bouma J; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Li X; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China., Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Mostinski Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Schippers M; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Gazzi T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., van der Horst C; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Brennecke B; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Hanske A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Kolomeets Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Guba W; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Sykes D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Broichhagen J; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Hua T; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China., Veprintsev D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK., Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Oddi S; Department of Veterinary Medicine, University of Teramo Via R. Balzarini 1 64100 Teramo Italy soddi@unite.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Grether U; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Nazare M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Publikováno v:
Chemical science [Chem Sci] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Autor:
Mohd S; Structural Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany., Oder A; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany., Specker E; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany., Neuenschwander M; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany., Von Kries JP; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany., Daumke O; Structural Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Publikováno v:
PloS one [PLoS One] 2024 Jul 29; Vol. 19 (7), pp. e0302704. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).
Autor:
Mach L; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Omran A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Bouma J; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands., Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Sykes DA; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, NG7 2UH Nottingham, U.K.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Edgbaston, B15 2TT Birmingham, Midlands, U.K., Guba W; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Li X; iHuman Institute, ShanghaiTech University, 201210 Shanghai, China.; School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China., Höffelmeyer C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Hentsch A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Gazzi T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Mostinski Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Wasinska-Kalwa M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., de Molnier F; IRR Chemistry Hub and Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, EH16 4UU Edinburgh, U.K., van der Horst C; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Vendrell M; IRR Chemistry Hub and Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, EH16 4UU Edinburgh, U.K., Hua T; iHuman Institute, ShanghaiTech University, 201210 Shanghai, China.; School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China., Veprintsev DB; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, NG7 2UH Nottingham, U.K.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Edgbaston, B15 2TT Birmingham, Midlands, U.K., Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands., Grether U; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Nazare M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Jul 25; Vol. 67 (14), pp. 11841-11867. Date of Electronic Publication: 2024 Jul 11.
Autor:
Becker PC; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Güth-Steffens M; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany., Lazarow K; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Sonntag N; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany., Braun D; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany., Masfaka I; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Renko K; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany.; German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany., Schomburg L; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany., Köhrle J; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Schweizer U; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany., Krause G; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Protze J; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Publikováno v:
Thyroid : official journal of the American Thyroid Association [Thyroid] 2024 Jul; Vol. 34 (7), pp. 920-930. Date of Electronic Publication: 2024 Jul 01.
DOTA-Based Plectin-1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue.
Autor:
Gazzi T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany., Lesina M; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Comprehensive Cancer Center München, Chair for Tumor Metabolism, School of Medicine and Health, Technical University of Munich, 81675, München, Germany., Wang Q; State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 100050, Beijing, China., Berninger A; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Comprehensive Cancer Center München, Chair for Tumor Metabolism, School of Medicine and Health, Technical University of Munich, 81675, München, Germany., Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany., Demir IE; Else Kröner Clinician Scientist Professor for Translational Pancreatic Surgery, Department of Surgery, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675, Munich, Germany., Kohlmann L; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Comprehensive Cancer Center München, Chair for Tumor Metabolism, School of Medicine and Health, Technical University of Munich, 81675, München, Germany., Meiser W; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany., Wilke S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany., Algül H; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Comprehensive Cancer Center München, Chair for Tumor Metabolism, School of Medicine and Health, Technical University of Munich, 81675, München, Germany., Hu HY; State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 100050, Beijing, China., Nazare M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Jun 21; Vol. 63 (26), pp. e202318485. Date of Electronic Publication: 2024 May 24.
Autor:
Brenner M; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Zink C; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Witzinger L; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Keller A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Hadamek K; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Bothe S; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany., Neuenschwander M; Leibniz Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany., Villmann C; Institute of Clinical Neurobiology, University Hospital, University of Würzburg, Würzburg, Germany., von Kries JP; Leibniz Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany., Schindelin H; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany., Jeanclos E; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany., Gohla A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.
Publikováno v:
ELife [Elife] 2024 Jun 10; Vol. 13. Date of Electronic Publication: 2024 Jun 10.
Autor:
Mehboob R; Lahore Medical Research Center, Lahore, Pakistan.; National Heart Lung and Blood Institute, National Institute of Health, Bethesda, MD, United States., Oehme P; Retired, Berlin, Germany., Anwar T; Lahore Medical Research Center, Lahore, Pakistan., von Kries JP; Retired, Berlin, Germany.
Publikováno v:
Frontiers in neurology [Front Neurol] 2024 May 30; Vol. 15, pp. 1370454. Date of Electronic Publication: 2024 May 30 (Print Publication: 2024).
Autor:
Gorenflos López JL; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Humboldt Universität zu Berlin, Department Chemie, Brook-Taylor-Strasse 2, 12489, Berlin, Germany., Dornan GL; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Boback N; Freie Universität Berlin, Institut für Pharmazie, Biopharmazeutika, Kelchstr. 31, 12169, Berlin, Germany., Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Oder A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Kemnitz-Hassanin K; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Schmieder P; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Specker E; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Asikoglu HC; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Berliner Hochschule für Technik (BHT), Seestrasse 64, 13347, Berlin, Germany., Oberdanner C; TECAN Group Ltd., Untersbergstraße 1a, 5082, Grödig, Austria., Seyffarth C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany., Lauster D; Freie Universität Berlin, Institut für Pharmazie, Biopharmazeutika, Kelchstr. 31, 12169, Berlin, Germany., Hinderlich S; Berliner Hochschule für Technik (BHT), Seestrasse 64, 13347, Berlin, Germany., Hackenberger CPR; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Humboldt Universität zu Berlin, Department Chemie, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.
Publikováno v:
Chembiochem : a European journal of chemical biology [Chembiochem] 2023 Dec 14; Vol. 24 (24), pp. e202300555. Date of Electronic Publication: 2023 Oct 16.
Autor:
Yan S; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Schöpe PC; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Lewis J; The European Molecular Biology Laboratory, EMBL, Meyerhofstraße 1, 69120 Heidelberg, Germany., Putzker K; The European Molecular Biology Laboratory, EMBL, Meyerhofstraße 1, 69120 Heidelberg, Germany., Uhrig U; The European Molecular Biology Laboratory, EMBL, Meyerhofstraße 1, 69120 Heidelberg, Germany., Specker E; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP, Robert-Rössle-Str. 10, 13125 Berlin, Germany., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Lindemann P; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Omran A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Sanchez-Ibarra HE; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Unger A; Lead Discovery Center GmbH, LDC, Otto-Hahn-Str. 15, 44227 Dortmund, Germany., Zischinsky ML; Lead Discovery Center GmbH, LDC, Otto-Hahn-Str. 15, 44227 Dortmund, Germany., Klebl B; Lead Discovery Center GmbH, LDC, Otto-Hahn-Str. 15, 44227 Dortmund, Germany., Walther W; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Nazaré M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP, Robert-Rössle-Str. 10, 13125 Berlin, Germany., Kobelt D; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany; German Cancer Consortium (DKTK Partnersite Berlin), Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Stein U; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany; German Cancer Consortium (DKTK Partnersite Berlin), Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Electronic address: ustein@mdc-berlin.de.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec; Vol. 168, pp. 115698. Date of Electronic Publication: 2023 Oct 21.